Dr. Thomas R. Jacques M.D.

Recommended Articles

• Judas Priest’s Glenn Tipton Diagnosed With Parkinson’s Disease

  Glenn Tipton, who is 70 years old and the infamous lead guitarist of Judas Priest, was diagnosed earlier this year with Parkinson’s disease. This diagnosis has prompted him to step down from the band's oncoming tour, because of how limited he would be in his performance.Glenn Tipton, born October...

• Imperative Information on Benzodiazepines: Lorazepam vs. Xanax

  What is lorazepam?Lorazepam is an anti-anxiety medication that belongs to the benzodiazepine class. It is prescribed to treat anxiety disorders and acts on the central nervous system by providing a calming effect. Lorazepam is sold under different brand names, which include Ativan, Almazine,...

• When Multiple Sclerosis Drugs Cause More Problems Than They Solve

  Unfortunately, treating multiple sclerosis can often feel like "one step forward, two steps back." It is not uncommon to feel as if the drugs for MS are doing more harm than good, and here is one way to look at the complicated relationship with medication.A cultural phenomenonGenerally, many suggest...

• The Brain Cell Transplant that Could Potentially Treat Parkinson’s Disease

  Parkinson’s Disease is a degenerative condition of the patient’s central nervous system which affects, among other things, the person’s motor functions. The disease initially manifests as involuntary movements such as shaking and difficulties to keep steady limbs, and can eventually evolve to...

• Multiple Sclerosis and Multi-Tasking

  Trying to multitask is enough to slow down anyone. However, this twofold action poses an even greater risk to multiple sclerosis (MS) patients: the risk of cognitive impairment. The impairment can be caused by shifting from one task to two tasks, known as the dual-task cost. ...

• Breakthrough Research on Facioscapulohumeral Muscular Dystrophy

  A study which was recently published in the Natural Communications journal, outlines a major breakthrough in research around facioscapulohumeral muscular dystrophy, also known as FSHD.The study was performed by the University of Minnesota Medical School. Researchers at the university inserted the...